Device / Technology News

RSS

HRM curve analysis identifies patients at risk of MH

A new DNA test may make it much simpler to identify patients at risk of malignant hyperthermia (MH)—a rare but life-threatening complication of exposure to common anesthetics reports the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

2 Nov 2011

NIH-funded project to discover biomarkers for type 2 diabetes

Arizona State University will lead a four-year, $5 million expanded initiative sponsored by the National Institutes of Health to discover proteins, or biomarkers, to help predict cardiovascular disease and to assess potential new treatments in people with type 2 diabetes.

2 Nov 2011

Young microenvironment rejuvenates old stem cells

Old stem cells can be rejuvenated by being placed in a young microenvironment, research from The University of Texas Health Science Center San Antonio shows. This raises the possibility that patients' own stem cells may one day be rescued and banked to treat their age-related diseases.

2 Nov 2011

Majority of body CT attending radiologists disagree on management of incidental findings

According to a recent study published in the November issue of the Journal of the American College of Radiology, many radiologists disagree on the management of incidental findings found on body computed tomography (CT) scans.

2 Nov 2011

Innovative mobile-technology strategy to prevent HIV/AIDS in Uganda

1 million people in Uganda live with HIV/AIDS, where long distances and expensive travel costs significantly limit access to treatment. By employing an innovative mobile-technology strategy, Dr. Femida Gwadry-Sridhar, Director of I-THINK Research at Lawson Health Research Institute, hopes to provide a much-needed solution.

2 Nov 2011

First orthotics study to use multi-segment foot model

It's one of those mysteries that has baffled runners and running doctors for decades: Why do orthotics work? Orthotics are commonly prescribed for painful conditions like plantar fasciitis, and, anecdotally, people swear by them, however scientists aren't exactly sure how they work. A recent study by University of Calgary Faculty of Kinesiology researcher Reed Ferber, PhD, published in the Journal of Foot and Ankle Research, suggests that to this point, scientists have been measuring the wrong thing.

2 Nov 2011

New protein microarray technology could eradicate malaria

A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.

2 Nov 2011

Interleukin Genetics commences two new PST test clinical studies in China

Interleukin Genetics, Inc. announced today that the Company has initiated two clinical studies to demonstrate the utility of its new PST genetic test in the ethnic Chinese population. The programs are being conducted in collaboration with Professor Chi-Cheng Tsai of Kaohsiung Medical University and Professor Dong Chen at Shanghai Stomatological Disease Center.

2 Nov 2011

MIT develops new software to speed up MRI scans

Magnetic resonance imaging (MRI) devices can scan the inside of the body in intricate detail, allowing clinicians to spot even the earliest signs of cancer or other abnormalities. But they can be a long and uncomfortable experience for patients, requiring them to lie still in the machine for up to 45 minutes.

2 Nov 2011

Hippocampus supports both recollection and familiarity memories

Human memory has historically defied precise scientific description, its biological functions broadly but imperfectly defined in psychological terms. In a pair of papers published in the November 2 issue of The Journal of Neuroscience, researchers at the University of California, San Diego report a new methodology that more deeply parses how and where certain types of memories are processed in the brain, and challenges earlier assumptions about the role of the hippocampus.

2 Nov 2011

FDA approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System

Abbott today announced it has received U.S. Food and Drug Administration (FDA) approval for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

2 Nov 2011

GSK, Alnylam collaborate to apply VaxiRNA technology for influenza vaccine production

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has formed a collaboration with GlaxoSmithKline (GSK) focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK, a leading vaccine manufacturer, is the first company to form a collaboration accessing this new platform.

2 Nov 2011

NovaSterilis reports significant findings from sterilization of absorbable suture study

NovaSterilis Inc. a leader in the development and commercialization of supercritical carbon dioxide (SCCO2) technology in collaboration with CC Chu Ph.D (Cornell) reports successful findings from research funded by a National Institutes of Health (NIH) phase l grant. These results meet the study goal to sterilize absorbable sutures to a sterility assurance level 10-6 (SAL6) without chemical or mechanical degradation. NovaSterilis intends to apply for phase II funding to develop the process ready for commercial application.

1 Nov 2011

LDR's ROI-A Oblique ALIF cage receives FDA marketing clearance

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the ROI-A Oblique ALIF cage. The oblique cage complements its forerunner, the ROI-A ALIF cage, which is designed for direct anterior insertion.

1 Nov 2011

ECMO and heart procedures performed as a bridge to lung transplantation

Surgeons at UK HealthCare recently became the first ever to perform two specific procedures together as a bridge to lung transplantation. Wanda Craig, of Lexington, Ky., is the first patient in history to receive these procedures, and at the age of 68, she is also the oldest living human to be bridged to transplant using an artificial lung device, also known as an extracorporeal membrane oxygenation (ECMO).

1 Nov 2011

New Mayo Clinic social network connects global community of esophageal cancer patients

In 2008, physicians at Mayo Clinic Florida led by Herbert Wolfsen, M.D., were looking for new ways to keep in touch with the large group of esophageal cancer patients cared for by him and other gastroenterologists and surgeons. Telephone calls, faxes and email had worked to create a network of patients but many now wanted interactive and remote access capability to share their experiences and challenges with this serious disease.

1 Nov 2011

Knife-edge scanning microscopy rapidly maps new blood vessels in organs

Like normal tissue, tumors thrive on nutrients carried to them by the blood stream. The rapid growth of new blood vessels is a hallmark of cancer, and studies have shown that preventing blood vessel growth can keep tumors from growing, too. To better understand the relationship between cancer and the vascular system, researchers would like to make detailed maps of the complete network of blood vessels in organs. Unfortunately, the current mapping process is time-consuming: using conventional methods, mapping a one-centimeter block of tissue can take months.

1 Nov 2011

Ultra-sensitive techniques for early detection of breast cancer

A team of scientists at Tufts University will develop ultra-sensitive techniques at the single-molecule and single-cell levels designed to detect breast cancer earlier, and treat it with greater precision, through a $6.6 million Innovator Award from the Department of Defense Breast Cancer Research Program made to Tufts chemist David R. Walt, Ph.D.

1 Nov 2011

Senior Scientific's nanomagnetic technology more sensitive in detecting breast cancer

Manhattan Scientifics announced today that "Breast Cancer Research," an international, peer-reviewed online journal, has published results of a study using Senior Scientific's nanomagnetic technology.

1 Nov 2011

Multi-centre phase II trial for new brain tumor surgical technique starts in the UK

A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK, jointly funded by Samantha Dickson Brain Tumour Trust and Cancer Research UK.

1 Nov 2011